DrugPatentWatch Database Preview
US Patent Family Members and Approved Drugs for World Intellectual Property Organization (WIPO) Patent: 2014152795
» See Plans and Pricing
US Patent Family Members and Approved Drugs for World Intellectual Property Organization (WIPO) Patent: WO2014152795
US Patent Number | Estimated Patent Expiration | Generic Name | US Applicant | US Tradename |
---|---|---|---|---|
Start Trial | 2033-03-14 | insulin aspart recombinant | Novo Nordisk Inc | NOVOLOG |
Start Trial | 2033-03-14 | insulin aspart recombinant | Novo Nordisk Inc | NOVOLOG PENFILL |
Start Trial | 2033-03-14 | insulin aspart recombinant | Novo Nordisk Inc | NOVOLOG FLEXPEN |
Start Trial | 2033-03-14 | insulin aspart recombinant | Novo Nordisk Inc | NOVOLOG INNOLET |
Start Trial | 2033-03-14 | insulin aspart recombinant | Novo Nordisk Inc | NOVOLOG FLEXTOUCH |
Start Trial | 2033-03-14 | insulin glargine recombinant | Sanofi Aventis Us | LANTUS |
Start Trial | 2033-03-14 | insulin glargine recombinant | Sanofi Aventis Us | LANTUS SOLOSTAR |
>US Patent Number | >Estimated Patent Expiration | >Generic Name | >US Applicant | >US Tradename |